Anti-HIV-1 antibodies: an update

W Promsote, ME DeMouth, CG Almasri, A Pegu - BioDrugs, 2020 - Springer
W Promsote, ME DeMouth, CG Almasri, A Pegu
BioDrugs, 2020Springer
Even after more than 30 years since its discovery, there is no cure for HIV-1 infection.
Combination antiretroviral therapy (cART) is currently the only HIV-1 infection management
option in clinics. Despite its success in suppressing viral replication and converting HIV-1
from a lethal infection to a chronic and manageable disease, cART treatment is life long and
long-term use can result in major drawbacks such as high cost, multiple side effects, and an
increase in the development of multidrug-resistant escape mutants. Recently, antibody …
Abstract
Even after more than 30 years since its discovery, there is no cure for HIV-1 infection. Combination antiretroviral therapy (cART) is currently the only HIV-1 infection management option in clinics. Despite its success in suppressing viral replication and converting HIV-1 from a lethal infection to a chronic and manageable disease, cART treatment is life long and long-term use can result in major drawbacks such as high cost, multiple side effects, and an increase in the development of multidrug-resistant escape mutants. Recently, antibody-based anti-HIV-1 treatment has emerged as a potential alternative therapeutic modality for HIV-1 treatment and cure strategies. These antibody-based anti-HIV-1 treatments comprising either receptor-targeting antibodies or broad neutralizing antibodies (bNAbs) are currently being developed and evaluated in clinical trials. These antibodies have demonstrated potent antiviral effects against multiple strains of HIV-1, and shown promise for prevention, maintenance, and prolonged remission of HIV-1 infection. This review gives an update on the current status of these antibody-based treatments for HIV-1, discusses their mechanism of action and the challenges in developing them, providing insight for their development as novel clinical therapies against HIV-1 infection.
Springer